The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.
Most Canadian physicians use electronic health records, but a lack of connectivity means that patient health information ...
Its program is generating meaningful net savings while expanding across more diagnoses and care settings. The model has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results